JPS6322782B2 - - Google Patents
Info
- Publication number
- JPS6322782B2 JPS6322782B2 JP56022192A JP2219281A JPS6322782B2 JP S6322782 B2 JPS6322782 B2 JP S6322782B2 JP 56022192 A JP56022192 A JP 56022192A JP 2219281 A JP2219281 A JP 2219281A JP S6322782 B2 JPS6322782 B2 JP S6322782B2
- Authority
- JP
- Japan
- Prior art keywords
- tartaric acid
- dipeptide
- tablet
- dipeptide sweetener
- sweeteners
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Seasonings (AREA)
Description
本発明はジペプチド甘味料含有発泡錠剤の製造
法に関する。
ジペプチド甘味料はシヨ糖とよく似た甘味質で
さわやかな甘味を有する低カロリー甘味料である
が、甘味料としての実用化を考える場合に、その
溶解性,分散性の低さが問題となる。このような
ジペプチド甘味料の溶解性,分散性を改善するた
めに、ジペプチド甘味料を発泡錠剤化化すること
が提案されている。
発泡錠剤は主剤および添加剤(賦形剤,結合
剤,崩壊剤,滑沢剤など)とともに炭酸塩もしく
は重炭酸塩と酸性物質を配合して製造される。製
造された錠剤は水中に投入すれば両者が中和して
炭酸ガス等のガスを発して速やかに溶解する。従
来、発泡剤として炭酸水素ナトリウムが広く用い
られ、その中和剤としてフマール酸が使用されて
いる。
しかしながら、このような発泡成分を配合した
場合、錠剤硬度の高いものが得られなかつたり、
あるいは高硬度の錠剤が得られても溶解性が著し
く劣る等の欠点があり、特に主剤としてジペプチ
ド甘味料を用いる場合にその改良が望まれてい
た。すなわち、甘味料を主剤とするものは耐磨損
性などの立場からある程度高い錠剤硬度を有し、
かつ使用時に速溶性であることが要求される。
本発明の目的は、このような要求を満足するジ
ペプチド甘味料含有発泡錠剤を提供することであ
る。
本発明はジペプチド甘味料含有発泡錠剤を製造
するにあたり、中和剤として酒石酸を添加するこ
とを特徴とするジペプチド甘味料含有発泡錠剤の
製造法に関するものである。
本発明において主剤としてジペプチド甘味料を
含有し、添加剤については、たとえば小麦でんぷ
ん、バレイシヨでんぷん、コーンスターチなどの
でんぷん類、ブドウ糖、シヨ糖、乳糖、ソルビツ
トなどの糖類、リン酸カルシウム,硫酸カルシウ
ムなどの無機物質等の賦形剤(または希釈剤);
でんぷん,シヨ糖,ゼラチン,アラビアゴム,メ
チルセルロース等の結合剤;炭酸水素ナトリウム
等の発泡剤;ロイシン,イソロイシン,L―バリ
ンなどの滑沢剤等があり、主剤との関係や錠剤の
製法等を考慮して適宜選択すればよい。本発明で
はさらに、上記発泡剤の中和剤として酒石酸を配
合する。
従来、中和剤としては酸性物質、特にフマール
酸が使用されていたが、他の有機酸を用いて錠剤
を製造し、錠剤硬度と溶解速度について検討した
ところ、錠剤を60℃の温水中で30秒以内に溶解さ
せるためには、フマール酸添加の場合は錠剤硬度
を1Kg程度に抑えなければならないのに対し、酒
石酸を加えた場合には、錠剤硬度を2.5〜4.0Kgと
しても速やかに溶解することを見出した。ここで
酒石酸としてはd型が好ましいが、dl型も使用で
きる。ジペプチド甘味料含有発泡錠剤の製造に際
しては公知の製法を適用でき、たとえば上記錠剤
成分を混合し、直接粉末圧縮法,湿式顆粒圧縮
法,乾式顆粒圧縮法等によつて製造することがで
きる。
中和剤としての酒石酸の添加量についてはジペ
プチド甘味料の種類,崩壊剤の添加量などを考慮
して決定されるが、たとえばジペプチド甘味料と
してα―L―アスパルチル―L―フエニルアラニ
ン・メチルエステル(以下、APと略す。)を用い
る場合は、使用時に迅速に溶解することが望まれ
るため、酒石酸を5〜35%の範囲で加えるべきで
あり、好ましい範囲は15〜25%である。なお、酒
石酸の添加量は使用する崩壊剤とモル等量とし、
すなわち速やかに中和反応を起す量が好ましい。
本発明によれば、錠剤硬度を2Kg以上(破壊硬
度)としても速溶性にすぐれた錠剤が得られる。
次に、本発明の実施例を示す。
実施例 1
下表の組成の錠剤組成物より乾式顆粒圧縮法に
よつてジペプチド甘味料含有発泡錠剤を製造し
た。
The present invention relates to a method for producing effervescent tablets containing dipeptide sweeteners. Dipeptide sweeteners are low-calorie sweeteners that have a refreshing sweetness similar to sucrose, but their low solubility and dispersibility pose problems when considering practical use as sweeteners. . In order to improve the solubility and dispersibility of such dipeptide sweeteners, it has been proposed to form dipeptide sweeteners into effervescent tablets. Effervescent tablets are manufactured by blending carbonate or bicarbonate and acidic substances with base ingredients and additives (excipients, binders, disintegrants, lubricants, etc.). When the manufactured tablets are placed in water, both are neutralized and gases such as carbon dioxide are released, causing them to dissolve quickly. Conventionally, sodium hydrogen carbonate has been widely used as a blowing agent, and fumaric acid has been used as a neutralizing agent. However, when such effervescent ingredients are blended, tablets with high hardness cannot be obtained or
Alternatively, even if highly hard tablets are obtained, there are drawbacks such as extremely poor solubility, and improvements have been desired, particularly when dipeptide sweeteners are used as the main ingredient. In other words, tablets containing sweeteners as the main ingredient have a certain degree of high tablet hardness from the standpoint of abrasion resistance, etc.
In addition, it is required to be quickly soluble during use. An object of the present invention is to provide an effervescent tablet containing a dipeptide sweetener that satisfies such requirements. The present invention relates to a method for producing effervescent tablets containing a dipeptide sweetener, characterized in that tartaric acid is added as a neutralizing agent during the production of effervescent tablets containing a dipeptide sweetener. In the present invention, the main ingredient is a dipeptide sweetener, and the additives include starches such as wheat starch, potato starch, and corn starch, sugars such as glucose, sucrose, lactose, and sorbitol, and inorganic substances such as calcium phosphate and calcium sulfate. Excipients (or diluents) such as;
There are binders such as starch, sucrose, gelatin, gum arabic, and methylcellulose; blowing agents such as sodium bicarbonate; and lubricants such as leucine, isoleucine, and L-valine. It is sufficient to take this into consideration and select it appropriately. In the present invention, tartaric acid is further blended as a neutralizing agent for the foaming agent. Conventionally, acidic substances, particularly fumaric acid, have been used as neutralizing agents, but when tablets were manufactured using other organic acids and the tablet hardness and dissolution rate were investigated, it was found that tablets were placed in hot water at 60°C. In order to dissolve within 30 seconds, if fumaric acid is added, the tablet hardness must be kept to around 1 kg, whereas if tartaric acid is added, the tablet dissolves quickly even if the tablet hardness is 2.5 to 4.0 kg. I found out what to do. Here, d-type tartaric acid is preferred, but dl-type tartaric acid can also be used. When producing effervescent tablets containing dipeptide sweeteners, known production methods can be applied; for example, the above tablet components may be mixed and produced by direct powder compression, wet granule compression, dry granule compression, or the like. The amount of tartaric acid added as a neutralizing agent is determined by considering the type of dipeptide sweetener, the amount of disintegrant added, etc. For example, α-L-aspartyl-L-phenylalanine methyl as a dipeptide sweetener When using an ester (hereinafter abbreviated as AP), tartaric acid should be added in a range of 5 to 35%, with a preferred range of 15 to 25%, since it is desired that it dissolves quickly during use. In addition, the amount of tartaric acid added is the molar equivalent of the disintegrant used,
That is, the amount that causes the neutralization reaction quickly is preferable. According to the present invention, a tablet with excellent rapid dissolution properties can be obtained even if the tablet hardness is 2 kg or more (breaking hardness). Next, examples of the present invention will be shown. Example 1 Effervescent tablets containing a dipeptide sweetener were manufactured from a tablet composition having the composition shown in the table below by a dry granule compression method.
【表】
上記各試料の諸性質についての測定結果を第2
表に示す。[Table] The measurement results for the various properties of each sample above are shown in the second table.
Shown in the table.
【表】【table】
【表】
第2表から明らかなように、試料3は外観にき
わめてすぐれており、しかも耐磨損性もよく、速
溶性であり、d―酒石酸がジペプチド甘味料含有
発泡錠剤においてすぐれた効果を有することが判
明した。
実施例 2
第3表の組成の錠剤組成物より乾式顆粒圧縮法
によつてジペプチド甘味料含有発泡錠剤を製造し
た。[Table] As is clear from Table 2, Sample 3 has an excellent appearance, good abrasion resistance, and quick dissolution, and d-tartaric acid has an excellent effect on effervescent tablets containing dipeptide sweeteners. It was found that it has. Example 2 A dipeptide sweetener-containing effervescent tablet was manufactured from a tablet composition having the composition shown in Table 3 by a dry granule compression method.
【表】
上記各試料の諸性質についての測定結果を第4
表に示す。[Table] The measurement results for the various properties of each sample above are shown in the 4th table.
Shown in the table.
【表】
上記結果より明らかなように、酒石酸の添加量
が5〜35%、好ましくは15〜25%の場合に、ジペ
プチド甘味料含有発泡錠剤として満足なものが得
られる。[Table] As is clear from the above results, satisfactory dipeptide sweetener-containing effervescent tablets can be obtained when the amount of tartaric acid added is 5 to 35%, preferably 15 to 25%.
Claims (1)
あたり、中和剤として酒石酸を添加することを特
徴とするジペプチド甘味料含有発泡錠剤の製造
法。 2 ジペプチド甘味料がα―L―アスパルチル―
L―フエニルアラニン・メチルエステルである特
許請求の範囲第1項記載の製造法。 3 酒石酸の添加量が5〜35%である特許請求の
範囲第1項記載の製造法。 4 酒石酸の添加量が15〜25%である特許請求の
範囲第1項記載の製造法。[Scope of Claims] 1. A method for producing an effervescent tablet containing a dipeptide sweetener, which comprises adding tartaric acid as a neutralizing agent in producing the effervescent tablet containing a dipeptide sweetener. 2 The dipeptide sweetener is α-L-aspartyl-
The manufacturing method according to claim 1, which is L-phenylalanine methyl ester. 3. The manufacturing method according to claim 1, wherein the amount of tartaric acid added is 5 to 35%. 4. The manufacturing method according to claim 1, wherein the amount of tartaric acid added is 15 to 25%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56022192A JPS57138358A (en) | 1981-02-19 | 1981-02-19 | Preparation of foaming tablet containing dipeptide sweetener |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56022192A JPS57138358A (en) | 1981-02-19 | 1981-02-19 | Preparation of foaming tablet containing dipeptide sweetener |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57138358A JPS57138358A (en) | 1982-08-26 |
| JPS6322782B2 true JPS6322782B2 (en) | 1988-05-13 |
Family
ID=12075930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56022192A Granted JPS57138358A (en) | 1981-02-19 | 1981-02-19 | Preparation of foaming tablet containing dipeptide sweetener |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57138358A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60199365A (en) * | 1984-03-22 | 1985-10-08 | Ajinomoto Co Inc | Composition containing amino acid |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4009292A (en) * | 1975-02-26 | 1977-02-22 | General Foods Corporation | Effervescent dipeptide sweetener tablets |
-
1981
- 1981-02-19 JP JP56022192A patent/JPS57138358A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57138358A (en) | 1982-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU689645B2 (en) | Salts of nefazodone having improved dissolution rates | |
| JPH05186334A (en) | Chewing or sucking tablet | |
| US20090291179A1 (en) | Method for producing high-protein soybean snack food | |
| US3441417A (en) | Beverage product and process | |
| JP2003292436A (en) | Hard sugar coating preparation, sugar coating liquid and manufacturing method of hard sugar coating preparation | |
| JPS5838250A (en) | Composite | |
| JPS62216910A (en) | Manufacture of dry carbon dioxide gas generating agent | |
| JPS6322782B2 (en) | ||
| HUP0003573A2 (en) | Acid salts of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester | |
| JP2002078463A (en) | Flavor enriched, powdery granular erythritol sweetener composition and method for producing the same | |
| US3769333A (en) | L-aspartic acid derivatives | |
| JP4948835B2 (en) | Hard coating layer, hard coating product and manufacturing method thereof | |
| CA1146591A (en) | Non-nutritive sweetener | |
| JPH0460624B2 (en) | ||
| CA2394902C (en) | Effervescent histamine h2 antagonist composition | |
| JPS61192800A (en) | Production of foamable cleanser | |
| US3814747A (en) | N-trihaloacetyl aspartic acid dipeptide ester sweetening agents | |
| JP2005516962A5 (en) | ||
| JPS6323820B2 (en) | ||
| US6497900B2 (en) | Effervescent base | |
| JPH0576307A (en) | Production of formed product of seasonings and soups | |
| CA1219767A (en) | Tableted beverage composition containing dipeptide sweetener and process | |
| JPH0622457B2 (en) | Tablets or granules containing dipeptide sweetener and method for producing the same | |
| JPH08322502A (en) | Molding seasoning and its manufacturing method | |
| JPH07165572A (en) | Oral preparation with bitter taste masking |